Lymphoma Drugs Market Research Reports

Market Spotlight: Waldenström Macroglobulinemia (WM) - Product Thumbnail Image

Market Spotlight: Waldenström Macroglobulinemia (WM)

  • Report
  • 32 Pages
From
Global Lymphoma Drugs Market 2017-2021 - Product Thumbnail Image

Global Lymphoma Drugs Market 2017-2021

  • Report
  • 86 Pages
From
Global Lymphoma Partnering 2012 to 2018 - Product Thumbnail Image

Global Lymphoma Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Partnering 2012 to 2018

  • Report
  • 150 Pages
From
CAS 23214-92-8 Adriamycin Chemical World Report - Product Thumbnail Image

CAS 23214-92-8 Adriamycin Chemical World Report

  • Report
  • 2153 Pages
CAS 936563-96-1 PCI-32765 Chemical World Report - Product Thumbnail Image

CAS 936563-96-1 PCI-32765 Chemical World Report

  • Report
  • 2069 Pages
Mantle Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Mantle Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 330 Pages
From
Cutaneous B- Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Cutaneous B- Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 74 Pages
From
T-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

T-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 359 Pages
From
Burkitt Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Burkitt Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 145 Pages
From
B-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

B-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 831 Pages
From
Diffuse Large B-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 532 Pages
From
Follicular Lymphoma Drug Profiles and Clinical Trials-Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Follicular Lymphoma Drug Profiles and Clinical Trials-Global Trends and Analysis Review, H2 2017

  • Report
  • 368 Pages
From
Anaplastic Large Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 128 Pages
From
Hodgkin Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Hodgkin Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • Report
  • 415 Pages
From
Cutaneous T-Cell Lymphoma Drug Profiles and Clinical Trials-Global Trends and Analysis Review, H2 2017 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma Drug Profiles and Clinical Trials-Global Trends and Analysis Review, H2 2017

  • Report
  • 157 Pages
From
Cutaneous T-Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecasts to 2027 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecasts to 2027

  • Report
  • 154 Pages
From
Mycosis Fungoides - Pipeline Insight, 2018 - Product Thumbnail Image

Mycosis Fungoides - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Insight, 2018 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Treanda - Drug Insight, 2018 - Product Thumbnail Image

Treanda - Drug Insight, 2018

  • Drug Pipelines
  • 35 Pages
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll